Articles – Page 7

AAKP Letter Re: Calcimimetics Drugs 8.12.21

August 20, 2021

August 11, 2021 The Honorable Chiquita Brooks-LaSure Administrator Centers for Medicare and Medicaid Services 200 Independence Avenue Southwest Washington, D.C. 20201 Dear Administrator Brooks-LaSure, As the oldest and largest kidney patient organization in the United States, the American Association of Kidney Patients (AAKP)

NEWS! CDC EMBRACES FDA AUTHORIZATION OF 3RD VACCINE DOSE FOR KIDNEY TRANSPLANT PATIENTS

August 13, 2021

NEWS! CDC EMBRACES FDA AUTHORIZATION OF 3RD VACCINE DOSE FOR KIDNEY TRANSPLANT PATIENTS The American Association of Kidney Patients (AAKP), the nation’s largest patient organization representing kidney transplant patients and living organ donors, thanks the Centers for Disease Control and Prevention (CDC)

AAKP Patient Impact Statement: FDA APPROVAL OF THIRD VACCINE DOSE FOR KIDNEY TRANSPLANT PATIENTS

August 13, 2021

FDA APPROVAL OF THIRD VACCINE DOSE FOR KIDNEY TRANSPLANT PATIENTS PATIENT IMPACT STATEMENT AMERICAN ASSOCIATION OF KIDNEY PATIENTS (AAKP) AMERICA’S LARGEST ORGANIZATION OF KIDNEY TRANSPLANT RECIPIENTS AND LIVING ORGAN DONORS WASHINGTON, D.C.

AMERICA’S LARGEST KIDNEY PATIENT GROUP OPENS NOMINATIONS FOR MEDAL OF EXCELLENCE

August 11, 2021

AMERICA’S LARGEST KIDNEY PATIENT GROUP OPENS NOMINATIONS FOR MEDAL OF EXCELLENCE American Association of Kidney Patients Spotlights Leaders in Kidney Care Amidst COVID Pandemic Washington, DC – The American Association of Kidney Patients (AAKP)

GRANT CYCLE OPENS FOR TOP AWARD FOR INNOVATIONS IN KIDNEY PATIENT SAFETY

August 9, 2021

TAMPA, FL – The American Association of Kidney Patients (AAKP), the largest kidney patient organization in America, announced the opening of the 2022 grant cycle for its AAKP Jenny Kitsen Patient Safety Award. AAKP works closely with the Centers for Disease Control and Prevention (CDC)

PATIENT IMPACT STATEMENT: FDA APPROVAL OF KERENDIA TO HELP SLOW KIDNEY DISEASE AND FAILURE ASSOCIATED WITH TYPE 2 DIABETES

July 14, 2021

PATIENT IMPACT STATEMENT: FDA APPROVAL OF KERENDIA TO HELP SLOW KIDNEY DISEASE AND FAILURE ASSOCIATED WITH TYPE 2 DIABETES WASHINGTON, D.C.

Kidney Patients Launch Education and Voter Registration Drive for Independence Day

July 1, 2021

Kidney Patients Launch Education and Voter Registration Drive for Independence Day Kidney Patriots™ Mobilize to Fight Disease Risks and Push for Care Innovation WASHINGTON, D.C. – The American Association of Kidney Patients (AAKP)

PHARMA, RESEARCH, AND MEDICAL LEADERS SAY KIDNEY PATIENTS ARE KEY TO CARE INNOVATION

June 25, 2021

FOR IMMEDIATE RELEASE: June 25, 2021 PHARMA, RESEARCH, AND MEDICAL LEADERS SAY KIDNEY PATIENTS ARE KEY TO CARE INNOVATION Kidney Patient-Led Policy Summit Targets Regulatory and Reimbursement Barriers to New Treatments WASHINGTON, D.C. – The American Association of Kidney Patients (AAKP)

TOP NIH KIDNEY RESEARCH DIRECTOR WINS PRESTIGIOUS AWARD FROM AMERICA’S PREMIER KIDNEY PATIENT GROUP

June 17, 2021

TOP NIH KIDNEY RESEARCH DIRECTOR WINS PRESTIGIOUS AWARD FROM AMERICA’S PREMIER KIDNEY PATIENT GROUP Dr. Griffin P. Rodgers Wins President’s Award from the American Association of Kidney Patients (AAKP) FOR IMMEDIATE RELEASE: June 17, 2021 Washington, D.C.: Today, the American Association of Kidney Patients (AAKP)

Letter to Rep. DelBene re Support of Vascular Graft Research 4.13.21

June 2, 2021

The Honorable Suzan DelBeneVice Chair of Congressional Caucus on DiabetesU.S. House of RepresentativesWashington, DC 20515 Dear Representative DelBene: